These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9398945)
1. Chemical speciation of arsenic in urine of patients with blackfoot disease. Lin TH; Huang YL Biol Trace Elem Res; 1995 Jun; 48(3):251-61. PubMed ID: 9398945 [TBL] [Abstract][Full Text] [Related]
2. Trace element concentration and arsenic speciation in the well water of a Taiwan area with endemic blackfoot disease. Chen SL; Yeh SJ; Yang MH; Lin TH Biol Trace Elem Res; 1995 Jun; 48(3):263-74. PubMed ID: 9398946 [TBL] [Abstract][Full Text] [Related]
3. Trace elements in hair of Blackfoot disease. Pan TC; Lin TH; Tseng CL; Yang MH; Huang CW Biol Trace Elem Res; 1993; 39(2-3):117-28. PubMed ID: 7509169 [TBL] [Abstract][Full Text] [Related]
4. Arsenic, selenium, and zinc in patients with Blackfoot disease. Lin SM; Yang MH Biol Trace Elem Res; 1988; 15():213-21. PubMed ID: 2484518 [TBL] [Abstract][Full Text] [Related]
5. Arsenic species in drinking water, hair, fingernails, and urine of patients with blackfoot disease. Lin TH; Huang YL; Wang MY J Toxicol Environ Health A; 1998 Jan; 53(2):85-93. PubMed ID: 9444313 [TBL] [Abstract][Full Text] [Related]
6. Speciation of key arsenic metabolic intermediates in human urine. Le XC; Lu X; Ma M; Cullen WR; Aposhian HV; Zheng B Anal Chem; 2000 Nov; 72(21):5172-7. PubMed ID: 11080860 [TBL] [Abstract][Full Text] [Related]
7. Concentration of arsenic, selenium, zinc, iron and copper in the urine of blackfoot disease patients at different clinical stages. Wang CT Eur J Clin Chem Clin Biochem; 1996 Jun; 34(6):493-7. PubMed ID: 8831051 [TBL] [Abstract][Full Text] [Related]
8. Sample preparation and storage can change arsenic speciation in human urine. Feldmann J; Lai VW; Cullen WR; Ma M; Lu X; Le XC Clin Chem; 1999 Nov; 45(11):1988-97. PubMed ID: 10545070 [TBL] [Abstract][Full Text] [Related]
9. Speciation of arsenic metabolite intermediates in human urine by ion-exchange chromatography and flow injection hydride generation atomic absorption spectrometry. Alauddin M; Alauddin ST; Bhattacharjee M; Sultana S; Chowdhury D; Bibi H; Rabbani GH J Environ Sci Health A Tox Hazard Subst Environ Eng; 2003 Jan; 38(1):115-28. PubMed ID: 12635822 [TBL] [Abstract][Full Text] [Related]
10. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Tseng CH; Huang YK; Huang YL; Chung CJ; Yang MH; Chen CJ; Hsueh YM Toxicol Appl Pharmacol; 2005 Aug; 206(3):299-308. PubMed ID: 16039941 [TBL] [Abstract][Full Text] [Related]
11. Determination and speciation of arsenic in human urine by ion-exchange chromatography/flow injection analysis with hydride generation/atomic absorption spectroscopy. Jimenez de Blas O; Vicente Gonzalez S; Seisdedos Rodriguez R; Hernandez Mendez J J AOAC Int; 1994; 77(2):441-5. PubMed ID: 8199481 [TBL] [Abstract][Full Text] [Related]
12. Bioaccessibility and excretion of arsenic in Niu Huang Jie Du Pian pills. Koch I; Sylvester S; Lai VW; Owen A; Reimer KJ; Cullen WR Toxicol Appl Pharmacol; 2007 Aug; 222(3):357-64. PubMed ID: 17239412 [TBL] [Abstract][Full Text] [Related]
13. Arsenic species contents at aquaculture farm and in farmed mouthbreeder (Oreochromis mossambicus) in blackfoot disease hyperendemic areas. Huang YK; Lin KH; Chen HW; Chang CC; Liu CW; Yang MH; Hsueh YM Food Chem Toxicol; 2003 Nov; 41(11):1491-500. PubMed ID: 12963001 [TBL] [Abstract][Full Text] [Related]
14. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Tseng CH; Chong CK; Chen CJ; Tai TY Atherosclerosis; 1996 Feb; 120(1-2):125-33. PubMed ID: 8645353 [TBL] [Abstract][Full Text] [Related]
15. Arsenic concentration in the urine of patients with Blackfoot disease and Bowen's disease. Lin SM; Chiang CH; Yang MH Biol Trace Elem Res; 1985 Aug; 8(1):11-8. PubMed ID: 24259224 [TBL] [Abstract][Full Text] [Related]
16. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan. Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952 [TBL] [Abstract][Full Text] [Related]
17. The speciation of the chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic. Foà V; Colombi A; Maroni M; Buratti M; Calzaferri G Sci Total Environ; 1984 Mar; 34(3):241-59. PubMed ID: 6719100 [TBL] [Abstract][Full Text] [Related]
18. Significance of arsenic metabolic forms in urine. Part I: Chemical speciation. Buratti M; Calzaferri G; Caravelli G; Colombi A; Maroni M; Foà V Int J Environ Anal Chem; 1984; 17(1):25-34. PubMed ID: 6724784 [TBL] [Abstract][Full Text] [Related]
19. Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic. Tseng WP Environ Health Perspect; 1977 Aug; 19():109-19. PubMed ID: 908285 [TBL] [Abstract][Full Text] [Related]
20. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]